BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/26/2021 8:04:00 AM | Browse: 343 | Download: 657
Publication Name World Journal of Gastrointestinal Surgery
Manuscript ID 66465
Country Japan
Received
2021-04-19 15:19
Peer-Review Started
2021-04-19 15:21
To Make the First Decision
Return for Revision
2021-08-09 18:34
Revised
2021-08-21 15:41
Second Decision
2021-09-13 02:28
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2021-09-17 00:41
Articles in Press
2021-09-17 00:41
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2021-10-22 01:52
Publish the Manuscript Online
2021-10-26 08:04
ISSN 1948-9366 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Surgery
Manuscript Type Retrospective Study
Article Title Outcomes of reduction hepatectomy combined with postoperative multidisciplinary therapy for advanced hepatocellular carcinoma
Manuscript Source Unsolicited Manuscript
All Author List Yoh Asahi, Toshiya Kamiyama, Tatsuhiko Kakisaka, Tatsuya Orimo, Shingo Shimada, Akihisa Nagatsu, Takeshi Aiyama, Yuzuru Sakamoto, Hirofumi Kamachi and Akinobu Taketomi
ORCID
Author(s) ORCID Number
Yoh Asahi http://orcid.org/0000-0002-0985-7874
Toshiya Kamiyama http://orcid.org/0000-0002-9157-7811
Tatsuhiko Kakisaka http://orcid.org/0000-0002-8556-5945
Tatsuya Orimo http://orcid.org/0000-0003-4398-0697
Shingo Shimada http://orcid.org/0000-0002-5187-6753
Akihisa Nagatsu http://orcid.org/0000-0002-4414-5530
Takeshi Aiyama http://orcid.org/0000-0001-5658-2730
Yuzuru Sakamoto http://orcid.org/0000-0002-0784-7971
Hirofumi Kamachi http://orcid.org/0000-0002-2839-8191
Akinobu Taketomi http://orcid.org/0000-0002-5238-3678
Funding Agency and Grant Number
Corresponding Author Yoh Asahi, MD, PhD, Surgeon, Department of Gastroenterological Surgery I, Hokkaido University Graduate School of Medicine, Kita-ku, Kita 15, Nishi 7, Sapporo 060-8638, Hokkaido, Japan. yoh-hibana@yk2.so-net.ne.jp
Key Words Hepatocellular carcinoma; Reduction hepatectomy; Multidisciplinary therapy; Tyrosine kinase inhibitors; Postoperative complete remission
Core Tip This was a retrospective study examining the outcomes of combination treatment with reduction hepatectomy and multidisciplinary postoperative treatment for advanced hepatocellular carcinoma (HCC). When reduction hepatectomy is performed for unresectable advanced HCC that is not indicated for curative hepatectomy, achieving postoperative complete remission (POCR) via postoperative multidisciplinary therapy is the key to success, with the 5-year overall survival rate and mean survival time for the POCR (+) group being 37.5% and 56.55 mo, respectively. To achieve POCR, reduction hepatectomy should be performed with the aim of reducing the number of tumors in the remnant liver to ≤ 3. Even in cases in which POCR is not achieved, tyrosine kinase inhibitor treatment might improve the prognosis of advanced HCC after reduction hepatectomy.
Publish Date 2021-10-26 08:04
Citation Asahi Y, Kamiyama T, Kakisaka T, Orimo T, Shimada S, Nagatsu A, Aiyama T, Sakamoto Y, Kamachi H, Taketomi A. Outcomes of reduction hepatectomy combined with postoperative multidisciplinary therapy for advanced hepatocellular carcinoma. World J Gastrointest Surg 2021; 13(10): 1245-1257
URL https://www.wjgnet.com/1948-9366/full/v13/i10/1245.htm
DOI https://dx.doi.org/10.4240/wjgs.v13.i10.1245
Full Article (PDF) WJGS-13-1245.pdf
Full Article (Word) WJGS-13-1245.docx
Manuscript File 66465_Auto_Edited.docx
Answering Reviewers 66465-Answering reviewers.pdf
Audio Core Tip 66465-Audio core tip.m4a
Biostatistics Review Certificate 66465-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form 66465-Conflict-of-interest statement.pdf
Copyright License Agreement 66465-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s) 66465-Informed consent statement.pdf
Institutional Review Board Approval Form or Document 66465-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate 66465-Language certificate.pdf
Peer-review Report 66465-Peer-review(s).pdf
Scientific Misconduct Check 66465-Bing-Wang LL-2.png
Scientific Editor Work List 66465-Scientific editor work list.pdf